Provided by Tiger Fintech (Singapore) Pte. Ltd.

Origin Agritech

1.01
+0.03003.06%
Volume:37.88K
Turnover:38.01K
Market Cap:7.27M
PE:-8.09
High:1.01
Open:0.9848
Low:0.9848
Close:0.9799
Loading ...

Origin Agritech Limited Files Amended Registration Statement with SEC for Prospectus

Reuters
·
30 Jun

Origin Agritech H1 EPS $(0.50), Sales $10.10M Down From $12.97M YoY

Benzinga
·
27 Jun

Origin Agritech Ltd. to Attend Major Agricultural Exhibition Highlighting Innovative Seed Varieties

Reuters
·
27 Jun

Origin Agritech Limited Delays Financial Reporting for Quarter Ending March 2025

Reuters
·
26 Jun

SEED Co., Ltd. Updates Mid-Term Management Plan

TIPRANKS
·
20 May

SEED Co., Ltd. Announces New Director Appointment

TIPRANKS
·
20 May

SEED Co., Ltd. Announces Dividend Payment for Fiscal Year 2025

TIPRANKS
·
20 May

SEED Co. Lifts Fiscal 2025 Consolidated Profit Outlook

MT Newswires Live
·
07 May

Press Release: BeyondSpring Reports 2024 Year-End Financial Results and Highlights Key Clinical & Strategic Milestones

Dow Jones
·
27 Mar

Origin Agritech’s Earnings Call: Growth Amid Challenges

TIPRANKS
·
14 Feb

Origin Agritech reports FY24 operating income $2.7M vs. $8.7M last year

TIPRANKS
·
11 Feb

Origin Agritech FY24 EPS $0.46 Down From $1.17 YoY, Sales $16.18M Up From $13.00M YoY

Benzinga
·
11 Feb

Press Release: Origin Agritech Reports 24.6% Revenue Growth and Key Technological Milestones in Fiscal Year 2024

Dow Jones
·
11 Feb

SEED Innovations Highlights Strong Growth in Little Green Pharma

TIPRANKS
·
31 Jan

SEED receives FDA Rare Pediatric Disease, Orphan Drug designations for ST-01156

TIPRANKS
·
28 Jan

BeyondSpring Announces $35.4 Million Sale of a Portion of Equity Interest in SEED Therapeutics to Advance Lead Asset Plinabulin to Anti-Cancer Registrational Studies

GlobeNewswire
·
28 Jan

Origin Agritech to Hold Business Update & Fiscal Year 2024 Earnings Conference Call on Tuesday, February 11th at 8 a.m. ET

PR Newswire
·
28 Jan

SEED Receives FDA Rare Pediatric Disease and Orphan Drug Designations for Lead Oncology Asset RBM39 Degrader and Enters Strategic Transactions with New Investors

GlobeNewswire
·
28 Jan

Origin Agritech Held Transgenic Breeding Seminar and Announces Partnerships with 12 Leading Agricultural Companies

PR Newswire
·
17 Jan

Origin Agritech Showcases Advanced Biotechnology Capabilities and Announces Landmark Partnership at International Seed Industry Conference

PR Newswire
·
16 Jan